ClinicalTrials.gg
Drug

Umbralisib clinical trials

Also written TGR-1202 and RP5264.

studies test it
29
open now
0
in phase 3
3
first study started
2013

How each study uses umbralisib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
5 Feb 2021 · UKONIQ · NDA 213176 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Umbralisib
18
2-((1S)-1-(4-Amino-3-(3-fluoro-4-(1-methylethoxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one
4

Brand

UKONIQ
1

Development codes

TGR-1202
25
RP5264
8

Studies by the year they started

29 studies that test it; most in 2016 (5)

Studies that test umbralisib, by start year
YearStudies
20132
20143
20153
20165
20173
20182
20195
20201
20213
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
19
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 16

TG Therapeutics, Inc. (13) · City of Hope Medical Center (2) · Columbia University (2) · National Cancer Institute (NCI) (1) · Jennifer R. Brown, MD, PhD (1) · University of Chicago (1) · Vanderbilt-Ingram Cancer Center (1) · Dana-Farber Cancer Institute (1)

Often tested with

Tested in the same studies.

Ublituximab (12) · Lenalidomide (2) · Acalabrutinib (1) · Tazemetostat (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses umbralisib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 29

See all 29 studies that test umbralisib →

Given beside what is tested · 5 — umbralisib is usual care or a partner of the new treatment

Codes

What other systems call umbralisib · ClinicalTrials.gg INT000901

  • MeSH (NLM) C000626319umbralisibOne source NLM
  • UNII (FDA) 38073MQB2AUMBRALISIBConfirmed FDA, NLM, Wikidata
  • RxNorm 2478439One source FDA
  • Wikidata Q27088612umbralisibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C104413UmbralisibOne source FDA
  • DrugBank DB14989One source Wikidata

Also registered as umbralisib tosylate (UNII FU8XW5V3FS · RxNorm 2478438).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.